Andlauer Healthcare Group Future Growth
Future criteria checks 0/6
Andlauer Healthcare Group is forecast to grow revenue at 4.6% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 110.8% |
| Revenue growth rate | 4.6% |
| Future return on equity | 15.0% |
| Analyst coverage | Good |
| Last updated | 18 Apr 2024 |
Recent future growth updates
Recent updates
These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well
Jan 30
Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing
Aug 24Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings
May 05Is Andlauer Healthcare Group (TSE:AND) Using Too Much Debt?
Apr 07A Look At The Fair Value Of Andlauer Healthcare Group Inc. (TSE:AND)
Dec 22Andlauer Healthcare Group (TSE:AND) Hasn't Managed To Accelerate Its Returns
Dec 09We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease
Oct 28These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Safely
Oct 12Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return
Aug 17We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease
Jul 19Andlauer Healthcare Group (TSE:AND) Could Easily Take On More Debt
Jul 05The Returns At Andlauer Healthcare Group (TSE:AND) Aren't Growing
May 04I Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease
Apr 19Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?
Feb 23Is There An Opportunity With Andlauer Healthcare Group Inc.'s (TSE:AND) 33% Undervaluation?
Jan 19We Think Andlauer Healthcare Group (TSE:AND) Might Have The DNA Of A Multi-Bagger
Jan 06Should You Be Adding Andlauer Healthcare Group (TSE:AND) To Your Watchlist Today?
Dec 15Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?
Nov 17Returns On Capital Are Showing Encouraging Signs At Andlauer Healthcare Group (TSE:AND)
Sep 20Is There An Opportunity With Andlauer Healthcare Group Inc.'s (TSE:AND) 44% Undervaluation?
Sep 03Do Andlauer Healthcare Group's (TSE:AND) Earnings Warrant Your Attention?
Aug 12Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?
May 29Why We Like The Returns At Andlauer Healthcare Group (TSE:AND)
May 03Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 737 | N/A | 128 | 150 | 1 |
| 12/31/2025 | 714 | N/A | 98 | 149 | 6 |
| 12/31/2024 | 681 | N/A | 93 | 141 | 7 |
| 12/31/2023 | 648 | 66 | 79 | 104 | N/A |
| 9/30/2023 | 645 | 67 | 87 | 116 | N/A |
| 6/30/2023 | 653 | 71 | 94 | 125 | N/A |
| 3/31/2023 | 665 | 76 | 102 | 132 | N/A |
| 12/31/2022 | 648 | 76 | 109 | 137 | N/A |
| 9/30/2022 | 616 | 110 | 109 | 129 | N/A |
| 6/30/2022 | 555 | 103 | 98 | 111 | N/A |
| 3/31/2022 | 493 | 95 | 85 | 97 | N/A |
| 12/31/2021 | 440 | 90 | 74 | 84 | N/A |
| 9/30/2021 | 394 | 51 | 54 | 61 | N/A |
| 6/30/2021 | 365 | 47 | 52 | 59 | N/A |
| 3/31/2021 | 328 | 41 | 51 | 58 | N/A |
| 12/31/2020 | 314 | 38 | 46 | 51 | N/A |
| 9/30/2020 | 304 | 31 | 64 | 72 | N/A |
| 6/30/2020 | 299 | 30 | 57 | 65 | N/A |
| 3/31/2020 | 300 | 31 | 54 | 61 | N/A |
| 12/31/2019 | 290 | 30 | 55 | 61 | N/A |
| 9/30/2019 | 285 | 28 | 44 | 49 | N/A |
| 12/31/2018 | 277 | 27 | 50 | 52 | N/A |
| 12/31/2017 | 251 | 22 | 40 | 43 | N/A |
| 12/31/2016 | 224 | 19 | N/A | 30 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if AND's forecast earnings growth is above the savings rate (2%).
Earnings vs Market: Insufficient data to determine if AND's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if AND's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AND's revenue (4.6% per year) is forecast to grow slower than the Canadian market (6.6% per year).
High Growth Revenue: AND's revenue (4.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AND's Return on Equity is forecast to be low in 3 years time (15%).